Signify Premium Insight: Exo Secures $220m in Series C Funding

Published: July 29, 2021

The handheld ultrasound market continues to garner investor interest, with Exo the latest company to benefit from a weighty funding round. The California-based start-up has announced it has raised $220m in a Series C investment round. The vendor says it is set to use the money to fund the commercialisation of its PMUT transducer,  dubbed Cello. Exo also has a handheld ultrasound scanner currently awaiting FDA approval, as well as its complementary point of care ultrasound workflow solution, Exo Works, in order to create an entire imaging workflow.


Already have an account? Sign in here